Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
Disease-modifying antirheumatic drugs are used in virtually all patients with established rheumatoid arthritis. An increasingly large number of new drugs is now available. Furthermore, old therapies are being used in novel ways. Treatment is now begun earlier and patients are rarely left untreated....
Κύριοι συγγραφείς: | Emery, P, Luqmani, R, Gordon, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1994
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
ανά: Abhishek Zanwar, κ.ά.
Έκδοση: (2017-01-01) -
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
ανά: Xia Y, κ.ά.
Έκδοση: (2016-05-01) -
The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.
ανά: Edwards, C, κ.ά.
Έκδοση: (2007) -
The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
ανά: Gregory Fleury, κ.ά.
Έκδοση: (2017-12-01) -
Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis
ανά: Yu. V. Muraviev, κ.ά.
Έκδοση: (2018-12-01)